Position in FOLD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$578,400
New position
Shares Held
40,000
first reported quarter
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GAMCO INVESTORS, INC. ET AL holds $3,917,413 across 8 Biotechnology names. FOLD ranks #4 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
21,000 | $844,830 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
13,150 | $742,843 | |
| 3 | NAGE |
Niagen Bioscience, Inc.
|
165,000 | $727,650 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
This page
|
40,000 | $578,400 | |
| 5 | VCEL |
Vericel Corp
|
15,495 | $498,474 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
639 | $493,716 | |
| 7 | CDXS |
Codexis, Inc.
|
10,000 | $16,300 | |
| 8 | CGTX |
Cognition Therapeutics Inc
|
20,000 | $15,200 |
All Filings in FOLD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $578,400 | 40,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||